These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 51920)

  • 21. [The influence of several membrane stabilizing drugs on the induced hereditary myotonia--a methodic way to test the effectiveness of drugs on myotonia (author's transl)].
    Wagner A; Zett L
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1981 Dec; 12(4):174-82. PubMed ID: 6277592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Membrane changes in cells from myotonia patients.
    Rüdel R; Lehmann-Horn F
    Physiol Rev; 1985 Apr; 65(2):310-56. PubMed ID: 2580324
    [No Abstract]   [Full Text] [Related]  

  • 23. Anaesthesia and myotonia.
    Russell SH; Hirsch NP
    Br J Anaesth; 1994 Feb; 72(2):210-6. PubMed ID: 8110575
    [No Abstract]   [Full Text] [Related]  

  • 24. Quantitative testing of handgrip strength, myotonia, and fatigue in myotonic dystrophy.
    Torres C; Moxley RT; Griggs RC
    J Neurol Sci; 1983 Jul; 60(1):157-68. PubMed ID: 6875612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of quinidine, procaine amide, and N-propyl-ajmaline on skeletal muscle.
    Senges J; Rüdel R; Kuhn E
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 276(1):25-33. PubMed ID: 4266249
    [No Abstract]   [Full Text] [Related]  

  • 26. Myotonic myopathy with painful muscle contractions and decrease of symptoms by cold.
    Rumpl E; Gerstenbrand F; Poewe W; Aichner J; Rainer J
    J Neurol; 1978 Oct; 219(2):133-7. PubMed ID: 81291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paramyotonia congenita: an electrophysiological study.
    Haynes J; Thrush DC
    Brain; 1972; 95(3):553-8. PubMed ID: 4655281
    [No Abstract]   [Full Text] [Related]  

  • 28. Quantitative myotonia assessment with a commercially available dynamometer in myotonic dystrophy types 1 and 2.
    Horáková M; Horák T; Parmová O; Bednařík J; Voháňka S
    Muscle Nerve; 2019 Apr; 59(4):431-435. PubMed ID: 30575988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Results of electromyographical and mechanographical investigations in myotonia congenita (author's transl)].
    Wagner A; Zett L
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1982 Mar; 13(1):14-21. PubMed ID: 6806065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myotonia not aggravated by cooling. Force and relaxation of the adductor pollicis in normal subjects and in myotonia as compared to paramyotonia.
    Ricker K; Hertel G; Langscheid K; Stodieck G
    J Neurol; 1977 Aug; 216(1):9-20. PubMed ID: 72799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the inhibition by chlorpromazine of myotonia induced by ion channel modulators in mouse skeletal muscle.
    Liu SH; Fu WM; Lin-Shiau SY
    Eur J Pharmacol; 1993 Jan; 231(1):23-30. PubMed ID: 7680317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myotonic dystrophy: quantification of muscle weakness and myotonia and the effect of amitriptyline and exercise.
    Milner-Brown HS; Miller RG
    Arch Phys Med Rehabil; 1990 Nov; 71(12):983-7. PubMed ID: 2241546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myotonia congenita. A histochemical and ultrastructural study in the goat: comparison with abnormalities found in human myotonia dystrophica.
    Atkinson JB; Swift LL; Lequire VS
    Am J Pathol; 1981 Mar; 102(3):324-35. PubMed ID: 7212017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical study of paramyotonia congenita with and without myotonia in a warm environment.
    Haass A; Ricker K; Rüdel R; Lehmann-Horn F; Böhlen R; Dengler R; Mertens HG
    Muscle Nerve; 1981; 4(5):388-95. PubMed ID: 6793868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Action potentials reconstructed in normal and myotonic muscle fibres.
    Adrian RH; Marshall MW
    J Physiol; 1976 Jun; 258(1):125-43. PubMed ID: 940049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Association of methylprednisolone dosing to cessation of myotonia in a patient with myotonic dystrophy type 1.
    Horáková M; Horák T; Bednařík J; Voháňka S
    Neuromuscul Disord; 2020 May; 30(5):427-430. PubMed ID: 32312586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of mexiletine on transitory depression of compound motor action potential in recessive myotonia congenita.
    Lo Monaco M; D'Amico A; Luigetti M; Desaphy JF; Modoni A
    Clin Neurophysiol; 2015 Feb; 126(2):399-403. PubMed ID: 25065301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1.
    Logigian EL; Martens WB; Moxley RT; McDermott MP; Dilek N; Wiegner AW; Pearson AT; Barbieri CA; Annis CL; Thornton CA; Moxley RT
    Neurology; 2010 May; 74(18):1441-8. PubMed ID: 20439846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myotonia fluctuans.
    Ricker K; Lehmann-Horn F; Moxley RT
    Arch Neurol; 1990 Mar; 47(3):268-72. PubMed ID: 2310311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The electrical properties of muscle fiber membranes in dystrophia myotonica and myotonia congenita.
    McComas AJ; Mrozek K
    J Neurol Neurosurg Psychiatry; 1968 Oct; 31(5):441-7. PubMed ID: 5709828
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.